At the request of BöösEnblad AB, Anders Fällman, Chairman of the Board, has decided to offer Anders Böös a seat on Carnegie’s nomination committee. BöösEnblad AB controls 9.2 percent of the share capital in Carnegie, according to a disclosure statement dated October 27, 2008. In addition to Anders Fällman, Moderna Finance, the following persons comprise the nomination committee: Carl Rosén (Chairman of the nomination committee), Second Swedish National Pension Fund (AP2); Jan Andersson, Swedbank Robur Fonder, and Greger Landstedt, Max Matthiessen.
Andreas Koch, Head of Communications and Investor Relations, + 46 8 676 86 39
D. Carnegie & Co must disclose the information provided herein pursuant to the Securities Market Act. The information was submitted for publication at 17:30 on October 29, 2008.